Psoriasis and metabolic comorbidities: The importance of well-designed prospective studies

Dermatology

Volumn 217, Issue 3, 2008, Pages 222-224

  Girolomoni, Giampiero ^a   Gisondi, Paolo ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANTIPSORIASIS AGENT; CYCLOSPORIN; ETANERCEPT; INFLIXIMAB; INTERLEUKIN 6; LEPTIN; METHOTREXATE; MONOCYTE CHEMOTACTIC PROTEIN 1; RESISTIN; RETINOID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VISFATIN;

CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COMORBIDITY; DIABETES MELLITUS; DIET; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENETIC CORRELATION; HUMAN; INFLAMMATORY DISEASE; INSULIN RESISTANCE; MEDICAL RESEARCH; METABOLIC DISORDER; METABOLIC SYNDROME X; NOTE; OBESITY; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RISK FACTOR; SIDE EFFECT; WEIGHT GAIN;

ARTHRITIS, PSORIATIC; CARDIOVASCULAR DISEASES; HUMANS; METABOLIC DISEASES; METABOLIC SYNDROME X; PSORIASIS;

EID: 47949124977     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000148247     Document Type: Note

References (21)

1. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM: Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006;55:829-835.
2. Mallbris L, Ritchlin CT, Stahle M: Metabolic disorders in patients with psoriasis and psoriatic arthritis. Curr Rheumatol Rep 2006;8:355-363.
3. Kimhi O, Caspi D, Bornstein NM, Maharshak N, Gur A, Arbel Y, Comaneshter D, Paran D, Wigler I, Levartovsky D, Berliner S, Elkayam O: Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum 2007;36:203-209.
4. Shapiro J, Cohen AD, David M, Hodak E, Chodik G, Viner A, Kremer E, Heymann A: The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007;56:629-634.
5. Wakkee M, Thio HB, Prens EP, Sijbrands EJ, Neumann HA: Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis 2007;190:1-9.
6. Mallbris L, Akre O, Granath F, Yin L, Lindelof B, Ekbom A, Stahle-Backdahl M: Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004;19:225-230.
7. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB: Risk of myocardial infarction in patients with psoriasis. JAMA 2006;296:1735-1741.
8. Ludwig RJ, Herzog C, Rostock A, Ochsendorf FR, Zollner TM, Thaci D, Kaufmann R, Vogl TJ, Boehncke WH: Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 2007;156:271-276.
9. Malerba M, Gisondi P, Radaeli A, Sala R, Calzavara Pinton P, Girolomoni G: Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. Br J Dermatol 2006;155:1165-1169.
10. Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, Giannetti A, Girolomoni G: Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007;157:68-73.
11. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 2005;365:1415-1428.
12. Wannamethee SG, Shaper AG, Lennon L, Morris RW: Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005;165:2644-2650.
13. Naldi L, Chatenoud L, Belloni A, Peserico A, Balato N, Virgili AR, Bruni PL, Ingordo V, Lo Scocco G, Solaroli C, Schena D, Di Landro A, Pezzarossa E, Arcangeli F, Gianni C, Betti R, Carli P, Farris A, Barbino GF, La Vecchia C, Parazzini F: Medical history, drug exposure and the risk of psoriasis. Evidence from an Italian case-control study. Dermatology 2008;216:125-130.
14. Herron MD, Hinckley M, Hoffman MS, Papenfuss J, Hansen CB, Callis KP, Krueger GG: Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005;141:1527-1534.
15. Mallbris L, Granath F, Hamsten A, Stahle M: Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol 2006;54:614-621.
16. Kremers HM, McEvoy MT, Dann FJ, Gabriel SE: Heart disease in psoriasis. J Am Acad Dermatol 2007;57:347-354.
17. Tilg H, Moschen AR: Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772-783.
18. Sherer Y, Shoenfeld Y: Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol 2006;2:99-106.
19. Hotamisligil GS: Inflammation and metabolic disorders. Nature 2006;444:860-867.
20. Naldi L, Griffiths CE: Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. Br J Dermatol 2005;152:597-615.
21. Gisondi P, Cotena C, Tessari G, Girolomoni G: Effects of anti-TNF-alpha treatments on body weight in patients with chronic plaque psoriasis: a retrospective cohort study. J Eur Acad Dermatol Venereol 2008;22:341-344.